The Experts below are selected from a list of 171 Experts worldwide ranked by ideXlab platform
Chang Gyu Park - One of the best experts on this subject based on the ideXlab platform.
-
Decrease in plasma adiponectin concentrations in patients with Variant Angina Pectoris.
Circulation, 2006Co-Authors: Soon Jun Hong, Dong Joo Oh, Jung Ah Kwon, Yangsoo Jang, Young Moo Ro, Chang Gyu ParkAbstract:Background Plasma adiponectin is decreased in patients with coronary artery diseases, especially in patients with acute coronary syndrome (ACS). However, the correlation between plasma adiponectin and Variant Angina Pectoris (VAP) has not been verified. Plasma adiponectin concentrations between VAP and other coronary artery diseases was compared in the present study. The association between plasma adiponectin concentration and VAP was also investigated. Methods and Results Plasma adiponectin concentrations in the VAP group (n=101) were compared with those of the ACS group (n=117), the stable Angina Pectoris group (n=108), and the normal coronary group (n=81). Plasma adiponectin concentrations in VAP and ACS were significantly lower than that of the normal coronary group (6.6±5.4 vs 5.2±4.0 vs 9.0 ±6.2 μg/ml, p
-
decrease in plasma adiponectin concentrations in patients with Variant Angina Pectoris
Circulation, 2006Co-Authors: Soon Jun Hong, Dong Joo Oh, Jung Ah Kwon, Yangsoo Jang, Young Moo Ro, Chang Gyu ParkAbstract:Background Plasma adiponectin is decreased in patients with coronary artery diseases, especially in patients with acute coronary syndrome (ACS). However, the correlation between plasma adiponectin and Variant Angina Pectoris (VAP) has not been verified. Plasma adiponectin concentrations between VAP and other coronary artery diseases was compared in the present study. The association between plasma adiponectin concentration and VAP was also investigated. Methods and Results Plasma adiponectin concentrations in the VAP group (n=101) were compared with those of the ACS group (n=117), the stable Angina Pectoris group (n=108), and the normal coronary group (n=81). Plasma adiponectin concentrations in VAP and ACS were significantly lower than that of the normal coronary group (6.6±5.4 vs 5.2±4.0 vs 9.0 ±6.2 μg/ml, p<0.001, respectively). Multivariate analysis indicated that plasma adiponectin (odds ratio (OR) 0.735, 95% confidence interval (CI) 0.621-0.855, p=0.011), smoking (OR 2.012, 95% CI 1.210-3.880, p=0.020), and age (OR 0.976, 95% CI 0.957-0.997, p=0.022) correlated independently with the development of VAP. Conclusions Our results suggest that a decrease in plasma adiponectin concentration might be associated with the development of VAP. (Circ J 2006; 70: 414 - 418)
David Simper - One of the best experts on this subject based on the ideXlab platform.
-
randomized double blind comparison of isosorbide dinitrate and nifedipine in Variant Angina Pectoris
American Journal of Cardiology, 1990Co-Authors: Michael Aschermann, J Bultas, Debora Karetova, Frantisek Kolbel, Michaela Kozakova, David SimperAbstract:Abstract The antiAnginal and anti-ischemic effect of isosorbide dinitrate (ISDN), 120 mg once daily, and nifedipine, 20 mg twice daily, both in slow-release formulations, were compared in 17 patients with Variant Angina Pectoris in a randomized, double-blind trial. The design included a placebo run-in period and two 6-week crossover periods of active treatment. Mean frequency of Angina decreased significantly from 43 attacks per week during the placebo period to 4 per week with ISDN and 8 with nifedipine (p Thus, both ISDN and nifedipine, in their slow-release formulations, are effective in the treatment of Variant Angina Pectoris.
Soon Jun Hong - One of the best experts on this subject based on the ideXlab platform.
-
Decrease in plasma adiponectin concentrations in patients with Variant Angina Pectoris.
Circulation, 2006Co-Authors: Soon Jun Hong, Dong Joo Oh, Jung Ah Kwon, Yangsoo Jang, Young Moo Ro, Chang Gyu ParkAbstract:Background Plasma adiponectin is decreased in patients with coronary artery diseases, especially in patients with acute coronary syndrome (ACS). However, the correlation between plasma adiponectin and Variant Angina Pectoris (VAP) has not been verified. Plasma adiponectin concentrations between VAP and other coronary artery diseases was compared in the present study. The association between plasma adiponectin concentration and VAP was also investigated. Methods and Results Plasma adiponectin concentrations in the VAP group (n=101) were compared with those of the ACS group (n=117), the stable Angina Pectoris group (n=108), and the normal coronary group (n=81). Plasma adiponectin concentrations in VAP and ACS were significantly lower than that of the normal coronary group (6.6±5.4 vs 5.2±4.0 vs 9.0 ±6.2 μg/ml, p
-
decrease in plasma adiponectin concentrations in patients with Variant Angina Pectoris
Circulation, 2006Co-Authors: Soon Jun Hong, Dong Joo Oh, Jung Ah Kwon, Yangsoo Jang, Young Moo Ro, Chang Gyu ParkAbstract:Background Plasma adiponectin is decreased in patients with coronary artery diseases, especially in patients with acute coronary syndrome (ACS). However, the correlation between plasma adiponectin and Variant Angina Pectoris (VAP) has not been verified. Plasma adiponectin concentrations between VAP and other coronary artery diseases was compared in the present study. The association between plasma adiponectin concentration and VAP was also investigated. Methods and Results Plasma adiponectin concentrations in the VAP group (n=101) were compared with those of the ACS group (n=117), the stable Angina Pectoris group (n=108), and the normal coronary group (n=81). Plasma adiponectin concentrations in VAP and ACS were significantly lower than that of the normal coronary group (6.6±5.4 vs 5.2±4.0 vs 9.0 ±6.2 μg/ml, p<0.001, respectively). Multivariate analysis indicated that plasma adiponectin (odds ratio (OR) 0.735, 95% confidence interval (CI) 0.621-0.855, p=0.011), smoking (OR 2.012, 95% CI 1.210-3.880, p=0.020), and age (OR 0.976, 95% CI 0.957-0.997, p=0.022) correlated independently with the development of VAP. Conclusions Our results suggest that a decrease in plasma adiponectin concentration might be associated with the development of VAP. (Circ J 2006; 70: 414 - 418)
Dong Joo Oh - One of the best experts on this subject based on the ideXlab platform.
-
Decrease in plasma adiponectin concentrations in patients with Variant Angina Pectoris.
Circulation, 2006Co-Authors: Soon Jun Hong, Dong Joo Oh, Jung Ah Kwon, Yangsoo Jang, Young Moo Ro, Chang Gyu ParkAbstract:Background Plasma adiponectin is decreased in patients with coronary artery diseases, especially in patients with acute coronary syndrome (ACS). However, the correlation between plasma adiponectin and Variant Angina Pectoris (VAP) has not been verified. Plasma adiponectin concentrations between VAP and other coronary artery diseases was compared in the present study. The association between plasma adiponectin concentration and VAP was also investigated. Methods and Results Plasma adiponectin concentrations in the VAP group (n=101) were compared with those of the ACS group (n=117), the stable Angina Pectoris group (n=108), and the normal coronary group (n=81). Plasma adiponectin concentrations in VAP and ACS were significantly lower than that of the normal coronary group (6.6±5.4 vs 5.2±4.0 vs 9.0 ±6.2 μg/ml, p
-
decrease in plasma adiponectin concentrations in patients with Variant Angina Pectoris
Circulation, 2006Co-Authors: Soon Jun Hong, Dong Joo Oh, Jung Ah Kwon, Yangsoo Jang, Young Moo Ro, Chang Gyu ParkAbstract:Background Plasma adiponectin is decreased in patients with coronary artery diseases, especially in patients with acute coronary syndrome (ACS). However, the correlation between plasma adiponectin and Variant Angina Pectoris (VAP) has not been verified. Plasma adiponectin concentrations between VAP and other coronary artery diseases was compared in the present study. The association between plasma adiponectin concentration and VAP was also investigated. Methods and Results Plasma adiponectin concentrations in the VAP group (n=101) were compared with those of the ACS group (n=117), the stable Angina Pectoris group (n=108), and the normal coronary group (n=81). Plasma adiponectin concentrations in VAP and ACS were significantly lower than that of the normal coronary group (6.6±5.4 vs 5.2±4.0 vs 9.0 ±6.2 μg/ml, p<0.001, respectively). Multivariate analysis indicated that plasma adiponectin (odds ratio (OR) 0.735, 95% confidence interval (CI) 0.621-0.855, p=0.011), smoking (OR 2.012, 95% CI 1.210-3.880, p=0.020), and age (OR 0.976, 95% CI 0.957-0.997, p=0.022) correlated independently with the development of VAP. Conclusions Our results suggest that a decrease in plasma adiponectin concentration might be associated with the development of VAP. (Circ J 2006; 70: 414 - 418)
Young Moo Ro - One of the best experts on this subject based on the ideXlab platform.
-
Decrease in plasma adiponectin concentrations in patients with Variant Angina Pectoris.
Circulation, 2006Co-Authors: Soon Jun Hong, Dong Joo Oh, Jung Ah Kwon, Yangsoo Jang, Young Moo Ro, Chang Gyu ParkAbstract:Background Plasma adiponectin is decreased in patients with coronary artery diseases, especially in patients with acute coronary syndrome (ACS). However, the correlation between plasma adiponectin and Variant Angina Pectoris (VAP) has not been verified. Plasma adiponectin concentrations between VAP and other coronary artery diseases was compared in the present study. The association between plasma adiponectin concentration and VAP was also investigated. Methods and Results Plasma adiponectin concentrations in the VAP group (n=101) were compared with those of the ACS group (n=117), the stable Angina Pectoris group (n=108), and the normal coronary group (n=81). Plasma adiponectin concentrations in VAP and ACS were significantly lower than that of the normal coronary group (6.6±5.4 vs 5.2±4.0 vs 9.0 ±6.2 μg/ml, p
-
decrease in plasma adiponectin concentrations in patients with Variant Angina Pectoris
Circulation, 2006Co-Authors: Soon Jun Hong, Dong Joo Oh, Jung Ah Kwon, Yangsoo Jang, Young Moo Ro, Chang Gyu ParkAbstract:Background Plasma adiponectin is decreased in patients with coronary artery diseases, especially in patients with acute coronary syndrome (ACS). However, the correlation between plasma adiponectin and Variant Angina Pectoris (VAP) has not been verified. Plasma adiponectin concentrations between VAP and other coronary artery diseases was compared in the present study. The association between plasma adiponectin concentration and VAP was also investigated. Methods and Results Plasma adiponectin concentrations in the VAP group (n=101) were compared with those of the ACS group (n=117), the stable Angina Pectoris group (n=108), and the normal coronary group (n=81). Plasma adiponectin concentrations in VAP and ACS were significantly lower than that of the normal coronary group (6.6±5.4 vs 5.2±4.0 vs 9.0 ±6.2 μg/ml, p<0.001, respectively). Multivariate analysis indicated that plasma adiponectin (odds ratio (OR) 0.735, 95% confidence interval (CI) 0.621-0.855, p=0.011), smoking (OR 2.012, 95% CI 1.210-3.880, p=0.020), and age (OR 0.976, 95% CI 0.957-0.997, p=0.022) correlated independently with the development of VAP. Conclusions Our results suggest that a decrease in plasma adiponectin concentration might be associated with the development of VAP. (Circ J 2006; 70: 414 - 418)
